HDAC11 and non-small cell lung carcinoma: Selective HDAC11 inhibitors, FT234 and FT895, reduced SOX2 expression in H1650 and A549 NSCLC cells and suppressed stemness properties, evidenced by reduced self-renewal and tumorsphere formation [485].